Pelago is a pioneering virtual clinic at the forefront of substance use management. By leveraging proprietary AI-native technology, the company provides personalized, accessible, and evidence-based support for members navigating challenges with tobacco, alcohol, and opioids. With a mission to destigmatize care, Pelago empowers individuals through a digital-first approach that seamlessly integrates with health plans and employer benefits.
Having recently secured $151 million in Series C funding, the company is in a phase of rapid expansion. Pelago's platform is currently trusted by hundreds of major employers, serving over 750,000 members. For professionals passionate about health equity and the intersection of technology and clinical care, Pelago offers a dynamic environment where innovation directly translates into life-changing support for thousands of people.